Evidence map›Paper›PMID 25548550›Full record

ReviewReviews in urology2014

Heterogeneity in active surveillance protocols worldwide.

Stacy Loeb, H Ballentine Carter, Mark Schwartz, Angela Fagerlin, R Scott Braithwaite, Herbert Lepor

Registry-linked trialAbstract readReview
In one paragraph

Review in Reviews in urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05698576 (TRANBERG® Transperineal MR/US Focalyx Fusion Laser--Induced Thermal Therapy in the Office Setting Under Local Anesthesia), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05698576 narecruitingnot on this mapstarted 2022, after this paper: background citation

TRANBERG® Transperineal MR/US Focalyx Fusion Laser--Induced Thermal Therapy in the Office Setting Under Local Anesthesia

TypeinterventionalSponsorUrological Research Network, LLCRan2022 to 2033Enrolled20ConditionsProstate Cancer, Adverse Effects Surgery, MRI, UltrasoundArmsTRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT)
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs.Medical decision making : an international journal of the Society for Medical Decision Making · 2019
    Article
  6. Biomarkers in active surveillance.Translational andrology and urology · 2018
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stacy Loeb
H Ballentine CarterThe James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD.
Mark SchwartzPopulation Health, New York University, New York, NY.
Angela Fagerlin
R Scott BraithwaitePopulation Health, New York University, New York, NY.
Herbert LeporDepartment of Urology New York, NY.

Funding

Optimal Strategy for Conservative Management of Prostate CancerK07CA178258 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LOEB, STACY · 2013 to 2017
$889k
NCI NIH HHS K07 CA178258
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25548550
PMCPMC4274180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.